The Department of Health (DH) today (25 November) endorsed a licensed drug wholesaler, Healthcare Pharmascience Limited (HCPS), to recall four batches (batch numbers: 109309, 111462, 119814, 122050) of the product, namely Clarem Tablets 250mg (Hong Kong Registration number: HK-66855) and a batch (batch number: 109392) of product, namely Clarem Tablets 500mg (Hong Kong Registration number: HK-66856) from the market as a precautionary measure due to the potential quality issue.

The DH received notification from HCPS that the overseas manufacturer of the products is recalling the above batches of Clarem tablets from the market because of misrepresentation of its active pharmaceutical ingredient (API) manufacturing site which is breaking the traceability of the supply chain of the API source. HCPS therefore is voluntarily recalling the affected batches from the market.

The above two products both contain clarithromycin in different strengths which are prescription medicines used for the treatment of bacterial infections. According to HCPS, the affected batches had been imported into Hong Kong and supplied to private doctors and pharmacies.

HCPS has set up a hotline 3472 8128 to answer related enquiries.

So far, the DH has not received any adverse reaction reports in connection with the products. The DH will closely monitor the recall.

Patients should not stop taking the products without talking to your doctors. If in doubt, please consult the healthcare professionals immediately.

-
Ends/ Tuesday, November 25, 2025